share_log

Transcode Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Marquet Magda

Transcode Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Marquet Magda

Transcode Therapeutics | 4:持股变动声明-董事 Marquet Magda
美股SEC公告 ·  2024/06/19 04:21

Moomoo AI 已提取核心信息

Transcode Therapeutics, Inc. [RNAZ] has reported a transaction involving Marquet Magda, a reporting person associated with the company. The transaction took place on 06/14/2024. However, the details regarding the relationship of Marquet Magda to the issuer, the nature of the transaction, the number of shares involved, and the transaction price were not disclosed in the announcement. Without this information, the impact of the transaction on Marquet Magda's holdings and the total value of shares post-transaction remain unclear.
Transcode Therapeutics, Inc. [RNAZ] has reported a transaction involving Marquet Magda, a reporting person associated with the company. The transaction took place on 06/14/2024. However, the details regarding the relationship of Marquet Magda to the issuer, the nature of the transaction, the number of shares involved, and the transaction price were not disclosed in the announcement. Without this information, the impact of the transaction on Marquet Magda's holdings and the total value of shares post-transaction remain unclear.
Transcode Therapeutics, Inc. [RNAZ]报告了一项涉及公司相关报告人Marquet Magda的交易。该交易于06/14/2024完成。然而,在公告中未透露Marquet Magda与发行人的关系、交易的性质、涉及的股份数量以及交易价格等细节。没有这些信息,无法确定交易对Marquet Magda持股及交易后的总股票价值的影响。
Transcode Therapeutics, Inc. [RNAZ]报告了一项涉及公司相关报告人Marquet Magda的交易。该交易于06/14/2024完成。然而,在公告中未透露Marquet Magda与发行人的关系、交易的性质、涉及的股份数量以及交易价格等细节。没有这些信息,无法确定交易对Marquet Magda持股及交易后的总股票价值的影响。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息